Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine

INTRODUCTION/OBJECTIVE: Chronic migraine (CM) is associated with impaired health-related quality of life and substantial socioeconomic burden, but many people with CM are underdiagnosed and do not receive appropriate preventive treatment. OnabotulinumtoxinA and topiramate have demonstrated efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Blumenfeld, Andrew M., Patel, Atul T., Turner, Ira M., Mullin, Kathleen B., Manack Adams, Aubrey, Rothrock, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536482/
https://www.ncbi.nlm.nih.gov/pubmed/32985341
http://dx.doi.org/10.1177/2150132720959936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536482/
https://www.ncbi.nlm.nih.gov/pubmed/32985341
http://dx.doi.org/10.1177/2150132720959936

Ejemplares similares